Health Care (CNBC)
The outdated health-care idea that's holding women back in life and careers
Women health CEOs say the presumption it's OK for women to 'suffer,' from early parenting to menopause, needs to be replaced by actual treatment and services.
6 hours 38 minutes ago
Checkout newsNovo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 23%
Novo Nordisk is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy copycats, with rare exceptions.
8 hours 30 minutes ago
Checkout newsPfizer CEO says tariff uncertainty is deterring further U.S. investment in manufacturing, R&D
It comes as drugmakers brace for Trump's levies on pharmaceuticals imported into the U.S. – his administration's bid to boost manufacturing in the country.
12 hours 39 minutes ago
Checkout newsPfizer expands cost cuts, tops quarterly profit estimates even as sales fall
Pfizer maintained its 2025 guidance but noted it does not include any impact of tariffs or trade policy, "which we are unable to predict at this time."
13 hours 13 minutes ago
Checkout newsOracle engineers caused dayslong software outage at U.S. hospitals
Oracle engineers triggered a five-day outage at several Community Health Systems hospitals, causing the facilities to temporarily return to paper-based records.
18 hours 42 minutes ago
Checkout newsNovo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic
Patients flocked to those Ozempic, Wegovy copycats when the branded drugs were in short supply, or if they didn't have insurance coverage for the treatments.
4 days 11 hours ago
Checkout newsMerck lowers profit outlook, partly due to $200 million expected tariff hit
Merck said the expected tariff charge primarily reflects levies between the U.S. and China, but does not account for Trump's planned pharmaceutical tariffs.
5 days 10 hours ago
Checkout newsWhy we're lowering our Bristol Myers price target despite an earnings beat, guidance raise
Shares of Bristol Myers Squibb fell modestly after the drugmaker's better-than-expected first-quarter results.
5 days 12 hours ago
Checkout newsBristol Myers Squibb tops quarterly estimates, hikes outlook as drugmaker braces for tariffs
The guidance revisions include the estimated impact of current tariffs on U.S. products shipped to China, but not Trump's planned pharmaceutical tariffs.
5 days 17 hours ago
Checkout newsEli Lilly sues four telehealth sites selling compounded Zepbound, Mounjaro
Eli Lilly & Co. is suing four telehealth companies selling compounded versions of Lilly's weight-loss drug Zepbound and its diabetes drug Mounjaro.
6 days 4 hours ago
Checkout newsFDA to phase out dyes used in Flamin' Hot Cheetos, Skittles and other snacks
The FDA is phasing out the use of petroleum-based synthetic dyes in food and drinks.
1 week ago
Checkout newsHealthy Returns: Trump seeks to change Medicare drug price negotiations in a win for pharma
Trump proposed a change to Medicare price talks that has long been sought after by the pharmaceutical industry.
1 week ago
Checkout newsDanaher's quarterly results show signs of life, and the struggling stock soars
Eli Lilly sues two pharmacies making copycat Zepbound, Mounjaro
Eli Lilly is suing Strive Pharmacy and Empower Pharmacy for compounding tirzepatide, the active ingredient in Zepbound and Mounjaro.
1 week 1 day ago
Checkout newsThese are the 4 biggest things we're watching in the stock market in the week ahead
First-quarter earnings season picks up speed inside our portfolio and outside of it.
1 week 2 days ago
Checkout newsUnitedHealth's stock is plunging on higher medical costs. That may mean trouble for more insurers
The warning sign from a health-care giant seen as the insurance industry's bellwether may mean trouble for companies with Medicare Advantage plans.
1 week 5 days ago
Checkout newsBrain implant cleared by FDA for Precision Neuroscience, a Musk Neuralink rival
Precision Neuroscience announced that a core component of its brain implant system has been approved by the FDA.
1 week 5 days ago
Checkout newsEli Lilly’s weight loss pill succeeds in first late-stage trial on diabetes patients; shares jump 14%
The results bring Eli Lilly's pill orforglipron one step closer to becoming a new, needle-free alternative in the booming weight loss and diabetes market.
1 week 5 days ago
Checkout newsEli Lilly shares surge on new obesity pill data. What it means for the stock from here
Jim Cramer said Eli Lilly's new trial data has turned the obesity market into a 'one-horse race.'
1 week 5 days ago
Checkout news23andMe bankruptcy under congressional investigation for customer data
The House Committee on Energy and Commerce is investigating 23andMe's decision to file for bankruptcy
1 week 5 days ago
Checkout news